Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 54 entries
Sorted by: Best Match Show Resources per page
Efficacy of Finasteride for Treating Patients with Androgenetic Alopecia who are Pileous in other Areas: A Pilot Study in Japan.

Indian journal of dermatology

Inadomi T.
PMID: 24700935
Indian J Dermatol. 2014 Mar;59(2):163-5. doi: 10.4103/0019-5154.127677.

BACKGROUND: Androgenetic alopecia (AGA) involves androgen-dependent hair loss and finasteride is an established treatment for the disease. However, reports of the influence of finasteride on hair growth in other areas of the body are lacking.AIMS: To investigate the effects...

Cite
Inadomi T. Efficacy of Finasteride for Treating Patients with Androgenetic Alopecia who are Pileous in other Areas: A Pilot Study in Japan. Indian J Dermatol. 2014;59(2):163-5doi: 10.4103/0019-5154.127677.
Inadomi, T. (2014). Efficacy of Finasteride for Treating Patients with Androgenetic Alopecia who are Pileous in other Areas: A Pilot Study in Japan. Indian journal of dermatology, 59(2), 163-5. https://doi.org/10.4103/0019-5154.127677
Inadomi, Toru. "Efficacy of Finasteride for Treating Patients with Androgenetic Alopecia who are Pileous in other Areas: A Pilot Study in Japan." Indian journal of dermatology vol. 59,2 (2014): 163-5. doi: https://doi.org/10.4103/0019-5154.127677
Inadomi T. Efficacy of Finasteride for Treating Patients with Androgenetic Alopecia who are Pileous in other Areas: A Pilot Study in Japan. Indian J Dermatol. 2014 Mar;59(2):163-5. doi: 10.4103/0019-5154.127677. PMID: 24700935; PMCID: PMC3969676.
Copy Download .nbib Format: NLM
A case of pemphigus foliaceus aggravated in an irradiated area by radiotherapy against breast cancer.

Indian journal of dermatology

Inadomi T.
PMID: 25657410
Indian J Dermatol. 2015 Jan-Feb;60(1):93-4. doi: 10.4103/0019-5154.147818.

No abstract available.

Cite
Inadomi T. A case of pemphigus foliaceus aggravated in an irradiated area by radiotherapy against breast cancer. Indian J Dermatol. 2015;60(1):93-4doi: 10.4103/0019-5154.147818.
Inadomi, T. (2015). A case of pemphigus foliaceus aggravated in an irradiated area by radiotherapy against breast cancer. Indian journal of dermatology, 60(1), 93-4. https://doi.org/10.4103/0019-5154.147818
Inadomi, Toru. "A case of pemphigus foliaceus aggravated in an irradiated area by radiotherapy against breast cancer." Indian journal of dermatology vol. 60,1 (2015): 93-4. doi: https://doi.org/10.4103/0019-5154.147818
Inadomi T. A case of pemphigus foliaceus aggravated in an irradiated area by radiotherapy against breast cancer. Indian J Dermatol. 2015 Jan-Feb;60(1):93-4. doi: 10.4103/0019-5154.147818. PMID: 25657410; PMCID: PMC4318076.
Copy Download .nbib Format: NLM
Proton pump inhibitors and hip fracture: cause for alarm?.

Gastroenterology

Inadomi JM, Somsouk MA.
PMID: 17484900
Gastroenterology. 2007 May;132(5):2063-5; discussion 2065. doi: 10.1053/j.gastro.2007.03.091.

No abstract available.

Cite
Inadomi JM, Somsouk MA. Proton pump inhibitors and hip fracture: cause for alarm?. Gastroenterology. 2007;132(5):2063-5; discussion 2065doi: 10.1053/j.gastro.2007.03.091.
Inadomi, J. M., & Somsouk, M. A. (2007). Proton pump inhibitors and hip fracture: cause for alarm?. Gastroenterology, 132(5), 2063-5; discussion 2065. https://doi.org/10.1053/j.gastro.2007.03.091
Inadomi, John M, and Somsouk, M A. "Proton pump inhibitors and hip fracture: cause for alarm?." Gastroenterology vol. 132,5 (2007): 2063-5; discussion 2065. doi: https://doi.org/10.1053/j.gastro.2007.03.091
Inadomi JM, Somsouk MA. Proton pump inhibitors and hip fracture: cause for alarm?. Gastroenterology. 2007 May;132(5):2063-5; discussion 2065. doi: 10.1053/j.gastro.2007.03.091. PMID: 17484900.
Copy Download .nbib Format: NLM
Update on the cost-effectiveness of screening for colorectal neoplasia.

Current opinion in gastroenterology

Inadomi JM.
PMID: 15699893
Curr Opin Gastroenterol. 2003 Jan;19(1):44-50. doi: 10.1097/00001574-200301000-00008.

Colorectal cancer is an ideal target for population screening because it is a prevalent disease with an identifiable precursor lesion that, when treated, favorably alters the natural history of the disease. Several strategies for screening have illustrated efficacy, including...

Cite
Inadomi JM. Update on the cost-effectiveness of screening for colorectal neoplasia. Curr Opin Gastroenterol. 2003;19(1):44-50doi: 10.1097/00001574-200301000-00008.
Inadomi, J. M. (2003). Update on the cost-effectiveness of screening for colorectal neoplasia. Current opinion in gastroenterology, 19(1), 44-50. https://doi.org/10.1097/00001574-200301000-00008
Inadomi, John M. "Update on the cost-effectiveness of screening for colorectal neoplasia." Current opinion in gastroenterology vol. 19,1 (2003): 44-50. doi: https://doi.org/10.1097/00001574-200301000-00008
Inadomi JM. Update on the cost-effectiveness of screening for colorectal neoplasia. Curr Opin Gastroenterol. 2003 Jan;19(1):44-50. doi: 10.1097/00001574-200301000-00008. PMID: 15699893.
Copy Download .nbib Format: NLM
Will virtual colonoscopy replace optical colonoscopy for colorectal cancer screening?.

Gastroenterology

Inadomi JM, Somsouk MA.
PMID: 17919513
Gastroenterology. 2007 Oct;133(4):1384-5; discussion 1385-6. doi: 10.1053/j.gastro.2007.08.049.

No abstract available.

Cite
Inadomi JM, Somsouk MA. Will virtual colonoscopy replace optical colonoscopy for colorectal cancer screening?. Gastroenterology. 2007;133(4):1384-5; discussion 1385-6doi: 10.1053/j.gastro.2007.08.049.
Inadomi, J. M., & Somsouk, M. A. (2007). Will virtual colonoscopy replace optical colonoscopy for colorectal cancer screening?. Gastroenterology, 133(4), 1384-5; discussion 1385-6. https://doi.org/10.1053/j.gastro.2007.08.049
Inadomi, John M, and Somsouk, M A. "Will virtual colonoscopy replace optical colonoscopy for colorectal cancer screening?." Gastroenterology vol. 133,4 (2007): 1384-5; discussion 1385-6. doi: https://doi.org/10.1053/j.gastro.2007.08.049
Inadomi JM, Somsouk MA. Will virtual colonoscopy replace optical colonoscopy for colorectal cancer screening?. Gastroenterology. 2007 Oct;133(4):1384-5; discussion 1385-6. doi: 10.1053/j.gastro.2007.08.049. PMID: 17919513.
Copy Download .nbib Format: NLM
Highly conductive [3×n] gold-ion clusters enclosed within self-assembled cages.

Angewandte Chemie (International ed. in English)

Kiguchi M, Inatomi J, Takahashi Y, Tanaka R, Osuga T, Murase T, Fujita M, Tada T, Watanabe S.
PMID: 23629917
Angew Chem Int Ed Engl. 2013 Jun 10;52(24):6202-5. doi: 10.1002/anie.201301665. Epub 2013 Apr 29.

No abstract available.

Cite
Kiguchi M, Inatomi J, Takahashi Y, et al. Highly conductive [3×n] gold-ion clusters enclosed within self-assembled cages. Angew Chem Int Ed Engl. 2013;52(24):6202-5doi: 10.1002/anie.201301665.
Kiguchi, M., Inatomi, J., Takahashi, Y., Tanaka, R., Osuga, T., Murase, T., Fujita, M., Tada, T., & Watanabe, S. (2013). Highly conductive [3×n] gold-ion clusters enclosed within self-assembled cages. Angewandte Chemie (International ed. in English), 52(24), 6202-5. https://doi.org/10.1002/anie.201301665
Kiguchi, Manabu, et al. "Highly conductive [3×n] gold-ion clusters enclosed within self-assembled cages." Angewandte Chemie (International ed. in English) vol. 52,24 (2013): 6202-5. doi: https://doi.org/10.1002/anie.201301665
Kiguchi M, Inatomi J, Takahashi Y, Tanaka R, Osuga T, Murase T, Fujita M, Tada T, Watanabe S. Highly conductive [3×n] gold-ion clusters enclosed within self-assembled cages. Angew Chem Int Ed Engl. 2013 Jun 10;52(24):6202-5. doi: 10.1002/anie.201301665. Epub 2013 Apr 29. PMID: 23629917.
Copy Download .nbib Format: NLM
Issues Related to BID Dosing of PPIs.

Gastroenterology & hepatology

Inadomi J.
PMID: 20733938
Gastroenterol Hepatol (N Y). 2010 Jun;6(6):369-70.

No abstract available.

Cite
Inadomi J. Issues Related to BID Dosing of PPIs. Gastroenterol Hepatol (N Y). 2010;6(6):369-70
Inadomi, J. (2010). Issues Related to BID Dosing of PPIs. Gastroenterology & hepatology, 6(6), 369-70.
Inadomi, John. "Issues Related to BID Dosing of PPIs." Gastroenterology & hepatology vol. 6,6 (2010): 369-70.
Inadomi J. Issues Related to BID Dosing of PPIs. Gastroenterol Hepatol (N Y). 2010 Jun;6(6):369-70. PMID: 20733938; PMCID: PMC2920586.
Copy Download .nbib Format: NLM
Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non-invasive tests for the diagnosis of advanced liver fibrosis in patients with non-alcoholic fatty liver disease.

Hepatology research : the official journal of the Japan Society of Hepatology

Inadomi C, Takahashi H, Ogawa Y, Oeda S, Imajo K, Kubotsu Y, Tanaka K, Kessoku T, Okada M, Isoda H, Akiyama T, Fukushima H, Yoneda M, Anzai K, Aishima S, Nakajima A, Eguchi Y.
PMID: 32090397
Hepatol Res. 2020 Jun;50(6):682-692. doi: 10.1111/hepr.13495. Epub 2020 Mar 25.

AIM: The Enhanced Liver Fibrosis (ELF) test comprises a logarithmic algorithm combining three serum markers of hepatic extracellular matrix metabolism. We aimed to evaluate the performance of ELF for the diagnosis of liver fibrosis and to compare it with...

Cite
Inadomi C, Takahashi H, Ogawa Y, et al. Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non-invasive tests for the diagnosis of advanced liver fibrosis in patients with non-alcoholic fatty liver disease. Hepatol Res. 2020;50(6):682-692doi: 10.1111/hepr.13495.
Inadomi, C., Takahashi, H., Ogawa, Y., Oeda, S., Imajo, K., Kubotsu, Y., Tanaka, K., Kessoku, T., Okada, M., Isoda, H., Akiyama, T., Fukushima, H., Yoneda, M., Anzai, K., Aishima, S., Nakajima, A., & Eguchi, Y. (2020). Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non-invasive tests for the diagnosis of advanced liver fibrosis in patients with non-alcoholic fatty liver disease. Hepatology research : the official journal of the Japan Society of Hepatology, 50(6), 682-692. https://doi.org/10.1111/hepr.13495
Inadomi, Chika, et al. "Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non-invasive tests for the diagnosis of advanced liver fibrosis in patients with non-alcoholic fatty liver disease." Hepatology research : the official journal of the Japan Society of Hepatology vol. 50,6 (2020): 682-692. doi: https://doi.org/10.1111/hepr.13495
Inadomi C, Takahashi H, Ogawa Y, Oeda S, Imajo K, Kubotsu Y, Tanaka K, Kessoku T, Okada M, Isoda H, Akiyama T, Fukushima H, Yoneda M, Anzai K, Aishima S, Nakajima A, Eguchi Y. Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non-invasive tests for the diagnosis of advanced liver fibrosis in patients with non-alcoholic fatty liver disease. Hepatol Res. 2020 Jun;50(6):682-692. doi: 10.1111/hepr.13495. Epub 2020 Mar 25. PMID: 32090397.
Copy Download .nbib Format: NLM
Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.

Preventive medicine

Croswell JM, Corley DA, Lafata JE, Haas JS, Inadomi JM, Kamineni A, Ritzwoller DP, Vachani A, Zheng Y.
PMID: 34217414
Prev Med. 2021 Oct;151:106595. doi: 10.1016/j.ypmed.2021.106595. Epub 2021 Jun 30.

COVID-19 has proved enormously disruptive to the provision of cancer screening, which does not just represent an initial test but an entire process, including risk detection, diagnostic follow-up, and treatment. Successful delivery of services at all points in the...

Cite
Croswell JM, Corley DA, Lafata JE, et al. Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond. Prev Med. 2021;151:106595doi: 10.1016/j.ypmed.2021.106595.
Croswell, J. M., Corley, D. A., Lafata, J. E., Haas, J. S., Inadomi, J. M., Kamineni, A., Ritzwoller, D. P., Vachani, A., Zheng, Y. (2021). Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond. Preventive medicine, 151106595. https://doi.org/10.1016/j.ypmed.2021.106595
Croswell, Jennifer M, et al. "Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond." Preventive medicine vol. 151 (2021): 106595. doi: https://doi.org/10.1016/j.ypmed.2021.106595
Croswell JM, Corley DA, Lafata JE, Haas JS, Inadomi JM, Kamineni A, Ritzwoller DP, Vachani A, Zheng Y. Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond. Prev Med. 2021 Oct;151:106595. doi: 10.1016/j.ypmed.2021.106595. Epub 2021 Jun 30. PMID: 34217414; PMCID: PMC8722181.
Copy Download .nbib Format: NLM
Perceptions on Barriers and Facilitators to Colonoscopy Completion After Abnormal Fecal Immunochemical Test Results in a Safety Net System.

JAMA network open

Issaka RB, Bell-Brown A, Snyder C, Atkins DL, Chew L, Weiner BJ, Strate L, Inadomi JM, Ramsey SD.
PMID: 34374771
JAMA Netw Open. 2021 Aug 02;4(8):e2120159. doi: 10.1001/jamanetworkopen.2021.20159.

IMPORTANCE: The effectiveness of stool-based colorectal cancer (CRC) screening, including fecal immunochemical tests (FITs), relies on colonoscopy completion among patients with abnormal results, but in safety net systems and federally qualified health centers, in which FIT is frequently used,...

Cite
Issaka RB, Bell-Brown A, Snyder C, et al. Perceptions on Barriers and Facilitators to Colonoscopy Completion After Abnormal Fecal Immunochemical Test Results in a Safety Net System. JAMA Netw Open. 2021;4(8):e2120159doi: 10.1001/jamanetworkopen.2021.20159.
Issaka, R. B., Bell-Brown, A., Snyder, C., Atkins, D. L., Chew, L., Weiner, B. J., Strate, L., Inadomi, J. M., & Ramsey, S. D. (2021). Perceptions on Barriers and Facilitators to Colonoscopy Completion After Abnormal Fecal Immunochemical Test Results in a Safety Net System. JAMA network open, 4(8), e2120159. https://doi.org/10.1001/jamanetworkopen.2021.20159
Issaka, Rachel B, et al. "Perceptions on Barriers and Facilitators to Colonoscopy Completion After Abnormal Fecal Immunochemical Test Results in a Safety Net System." JAMA network open vol. 4,8 (2021): e2120159. doi: https://doi.org/10.1001/jamanetworkopen.2021.20159
Issaka RB, Bell-Brown A, Snyder C, Atkins DL, Chew L, Weiner BJ, Strate L, Inadomi JM, Ramsey SD. Perceptions on Barriers and Facilitators to Colonoscopy Completion After Abnormal Fecal Immunochemical Test Results in a Safety Net System. JAMA Netw Open. 2021 Aug 02;4(8):e2120159. doi: 10.1001/jamanetworkopen.2021.20159. PMID: 34374771; PMCID: PMC8356069.
Copy Download .nbib Format: NLM
Pancreatic acinar cell carcinoma presenting with panniculitis, successfully treated with FOLFIRINOX: A case report.

Molecular and clinical oncology

Yoshihiro T, Nio K, Tsuchihashi K, Ariyama H, Kohashi K, Tsuruta N, Hanamura F, Inadomi K, Ito M, Sagara K, Okumura Y, Nakano M, Arita S, Kusaba H, Oda Y, Akashi K, Baba E.
PMID: 28588779
Mol Clin Oncol. 2017 Jun;6(6):866-870. doi: 10.3892/mco.2017.1240. Epub 2017 May 05.

Pancreatic acinar cell carcinoma (PACC) is a rare tumor of the exocrine pancreas, representing only 1% of all pancreatic malignancies. A 50-year-old man presented with edema of the thumb joints bilaterally, followed by an appearance of masses in the...

Cite
Yoshihiro T, Nio K, Tsuchihashi K, et al. Pancreatic acinar cell carcinoma presenting with panniculitis, successfully treated with FOLFIRINOX: A case report. Mol Clin Oncol. 2017;6(6):866-870doi: 10.3892/mco.2017.1240.
Yoshihiro, T., Nio, K., Tsuchihashi, K., Ariyama, H., Kohashi, K., Tsuruta, N., Hanamura, F., Inadomi, K., Ito, M., Sagara, K., Okumura, Y., Nakano, M., Arita, S., Kusaba, H., Oda, Y., Akashi, K., & Baba, E. (2017). Pancreatic acinar cell carcinoma presenting with panniculitis, successfully treated with FOLFIRINOX: A case report. Molecular and clinical oncology, 6(6), 866-870. https://doi.org/10.3892/mco.2017.1240
Yoshihiro, Tomoyasu, et al. "Pancreatic acinar cell carcinoma presenting with panniculitis, successfully treated with FOLFIRINOX: A case report." Molecular and clinical oncology vol. 6,6 (2017): 866-870. doi: https://doi.org/10.3892/mco.2017.1240
Yoshihiro T, Nio K, Tsuchihashi K, Ariyama H, Kohashi K, Tsuruta N, Hanamura F, Inadomi K, Ito M, Sagara K, Okumura Y, Nakano M, Arita S, Kusaba H, Oda Y, Akashi K, Baba E. Pancreatic acinar cell carcinoma presenting with panniculitis, successfully treated with FOLFIRINOX: A case report. Mol Clin Oncol. 2017 Jun;6(6):866-870. doi: 10.3892/mco.2017.1240. Epub 2017 May 05. PMID: 28588779; PMCID: PMC5451886.
Copy Download .nbib Format: NLM
Reply.

Gastroenterology

Wernli KJ, Brenner AT, Rutter CM, Inadomi JM.
PMID: 27496674
Gastroenterology. 2016 Sep;151(3):564. doi: 10.1053/j.gastro.2016.07.041. Epub 2016 Aug 03.

No abstract available.

Cite
Wernli KJ, Brenner AT, Rutter CM, et al. Reply. Gastroenterology. 2016;151(3):564doi: 10.1053/j.gastro.2016.07.041.
Wernli, K. J., Brenner, A. T., Rutter, C. M., & Inadomi, J. M. (2016). Reply. Gastroenterology, 151(3), 564. https://doi.org/10.1053/j.gastro.2016.07.041
Wernli, Karen J, et al. "Reply." Gastroenterology vol. 151,3 (2016): 564. doi: https://doi.org/10.1053/j.gastro.2016.07.041
Wernli KJ, Brenner AT, Rutter CM, Inadomi JM. Reply. Gastroenterology. 2016 Sep;151(3):564. doi: 10.1053/j.gastro.2016.07.041. Epub 2016 Aug 03. PMID: 27496674; PMCID: PMC6386153.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 54 entries